NewGenIvf (NIVFW) Liabilities and Shareholders Equity (2022 - 2025)

NewGenIvf (NIVFW) has 4 years of Liabilities and Shareholders Equity data on file, last reported at $32.7 million in Q4 2025.

• In Q4 2025, Liabilities and Shareholders Equity rose 814.62% year-over-year to $32.7 million; the TTM figure through Dec 2025 stood at $43.7 million (changed N/A YoY), while the FY2025 annual figure was $32.7 million, up 814.62% from the prior year.
• Liabilities and Shareholders Equity rose to $32.7 million in Q4 2025, from $3.6 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $32.7 million in Q4 2025 and bottomed at $2.9 million in Q4 2022.
• A 4-year average of $10.9 million and a median of $4.0 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity retreated 20.26% — and 2025, when it jumped 814.62%.
• Year by year, Liabilities and Shareholders Equity stood at $2.9 million in 2022, then soared by 54.46% to $4.5 million in 2023, then retreated by 20.26% to $3.6 million in 2024, then jumped by 814.62% to $32.7 million in 2025.
• The last three Liabilities and Shareholders Equity figures came in at $32.7 million (Q4 2025), $3.6 million (Q4 2024), and $4.5 million (Q4 2023), per Business Quant data.

Peer Comparison